Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa
Open Access
- 1 April 2011
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 19 (4), 642-649
- https://doi.org/10.1038/mt.2010.293
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78Proceedings of the National Academy of Sciences, 2010
- Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector AdministrationMolecular Therapy, 2010
- Little Vector, Big Gene Transduction: Fragmented Genome Reassembly of Adeno-associated VirusMolecular Therapy, 2010
- Characterization of Genome Integrity for Oversized Recombinant AAV VectorMolecular Therapy, 2010
- Evidence for the Failure of Adeno-associated Virus Serotype 5 to Package a Viral Genome ≥8.2 kbMolecular Therapy, 2010
- Effect of Genome Size on AAV Vector PackagingMolecular Therapy, 2010
- Functional Cone Rescue by RdCVF Protein in a Dominant Model of Retinitis PigmentosaMolecular Therapy, 2009
- Improved Retinal Function in a Mouse Model of Dominant Retinitis Pigmentosa Following AAV-delivered Gene TherapyMolecular Therapy, 2009
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Effect of Gene Therapy on Visual Function in Leber's Congenital AmaurosisNew England Journal of Medicine, 2008